CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.

2014
https://researcherprofiles.org/profile/1183145
25051018
Kitzmiller JP, Luzum JA, Baldassarre D, Krauss RM, Medina MW